Status:

COMPLETED

Rehabilitation Following Displaced Proximal Humerus Fractures

Lead Sponsor:

Zealand University Hospital

Collaborating Sponsors:

University of Southern Denmark

University of Copenhagen

Conditions:

Shoulder Fractures

Eligibility:

All Genders

60+ years

Phase:

NA

Brief Summary

Proximal humerus fractures (PHFs) are the third most common non-vertebral fractures in the elderly. Most elderly experience loss of function following a PHF regardless of treatment. A Cochrane review ...

Detailed Description

Proximal humerus fractures (PHFs) are the closely related to osteoporosis. The lifetime risk of suffering a PHF in females aged 50 or above is 13%. About half of the fractures are minimally displaced ...

Eligibility Criteria

Inclusion

  • • Patients aged 60 years or above with displaced PHFs (Neer's definition) including 2-, 3-, or 4-part fractures after a low energy trauma will be recruited.
  • Prior to first visit in the outpatient clinic all patients with PHFs will be screened for eligibility based on initial radiographs and medical records by an experienced orthopaedic consultant (senior author SB) at Zealand University Hospital, Køge, Denmark. The senior author classifies fracture categories.
  • • Patients should be cognitively capable of answering patient-reported outcome measures.

Exclusion

  • Dependent on daily personal care for basic activities of daily living
  • Diagnosed with dementia or institutionalized
  • Does not understand written and spoken guidance in Danish
  • Pathological fracture or previous fracture in the same proximal humerus
  • Concomitant injury or fracture.
  • Polytrauma, high-energy trauma, or multiple fractures
  • Fracture dislocation or articular surface fracture
  • Isolated tuberosity fracture
  • Fractures not expected to heal by non-surgical treatment (no bony contact between head and shaft in both views)
  • The senior author considers the patient unsuitable to attend the study for medical reasons (substance abuse, affective or psychotic disorders, apoplexy, chronic pain, malignant disease)
  • Symptomatic glenohumeral osteoarthritis, rheumatoid arthritis, or rotator cuff-arthropathy

Key Trial Info

Start Date :

May 5 2022

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

January 20 2025

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT05302089

Start Date

May 5 2022

End Date

January 20 2025

Last Update

February 11 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Department of Orthopaedics, Zealand University Hospital

Køge, Denmark, 4600